HomeNDC LookupRxCUI directory › RxCUI 995241

Hydroxyzine hydrochloride 2 MG/ML Oral Solution — RxCUI 995241

RxNorm drug concept · Semantic clinical drug
RxCUI 995241 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 14 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI995241
Official nameHydroxyzine hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydroxyzine hydrochloride 10 MG per 5 ML Oral Solution; hydrOXYzine HCl 10 MG in 5 mL Oral Solution
FDA products mapped13
Package NDCs mapped14
Reported Medicaid activity (SDUD)311,619 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydroxyzine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Hydroxyzine is most often used to relieve anxiety and tension, or to control itching from allergic conditions like hives or eczema. It's also used as a calming medication before su...
  • Drowsiness is the most common side effect — it's actually how the medication works, so some sleepiness is expected, especially when you first start. For most people it gets better...
  • This is really important to go over with your pharmacist or doctor, because hydroxyzine interacts with a number of common drugs. Combining it with alcohol, opioid pain medicines, s...
  • Can I take hydroxyzine with my other medications?
📖 Read our full Hydroxyzine guide →

🕸️ Concept Web — How Hydroxyzine hydrochloride 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydroxyzine hydrochloride 2 MG/ML Oral Solution RxCUI 995241

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydroxyzine 5553
    • Hydroxyzine hydrochloride 154987
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydroxyzine Oral Solution 372441
    • Hydroxyzine hydrochloride Oral Solution 2649186
    • Hydroxyzine Oral Liquid Product 1164645
    • Hydroxyzine Oral Product 1164646
    • Hydroxyzine hydrochloride Oral Liquid Product 2661118
    • Hydroxyzine hydrochloride Oral Product 2660034
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydroxyzine hydrochloride 2 MG/ML 995240

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydroxyzine hydrochloride 2 MG/ML SCDC · 995240
  • Hydroxyzine Oral Solution SCDF · 372441
  • Hydroxyzine hydrochloride Oral Solution SCDFP · 2649186
  • Hydroxyzine Oral Liquid Product SCDG · 1164645
  • Hydroxyzine Oral Product SCDG · 1164646
  • Hydroxyzine hydrochloride Oral Liquid Product SCDGP · 2661118
  • Hydroxyzine hydrochloride Oral Product SCDGP · 2660034

📦 FDA Products & Package NDCs

13 products · 14 package NDCs
14 package NDCs map to RxCUI 995241 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-1034-16 473 mL in 1 BOTTLE (0121-1034-16) Hydroxyzine Hydrochloride PAI Holdings, LLC dba PAI Pharma 2024-11-14
17856-0507-01 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0507-1) / 5 mL... Hydroxyzine Hydrochloride ATLANTIC BIOLOGICALS CORP. 2024-05-08
54838-0502-80 473 mL in 1 BOTTLE, PLASTIC (54838-502-80) Hydroxyzine Hydrochloride Lannett Company, Inc. 2013-08-21
62135-0050-24 2 TRAY in 1 BOX (62135-050-24) / 10 CUP in 1 TRAY / 25 mL i... HYDROXYZINE HYDROCHLORIDE Chartwell RX, LLC 2024-09-23
62135-0502-47 473 mL in 1 BOTTLE (62135-502-47) Hydroxyzine Hydrochloride Chartwell RX, LLC 2022-10-03
62135-0750-47 473 mL in 1 BOTTLE (62135-750-47) HYDROXYZINE HYDROCHLORIDE Chartwell RX, LLC 2023-08-09
63187-0494-04 118 mL in 1 BOTTLE, PLASTIC (63187-494-04) Hydroxyzine Hydrochloride Proficient Rx LP 2015-02-02
68999-0050-24 2 TRAY in 1 BOX (68999-050-24) / 10 CUP in 1 TRAY / 25 mL i... HYDROXYZINE HYDROCHLORIDE Chartwell Governmental & Specialty RX, LLC. 2025-10-31
69452-0395-88 473 mL in 1 BOTTLE (69452-395-88) Hydroxyzine Hydrochloride Bionpharma Inc. 2025-07-17
70954-0912-10 473 mL in 1 BOTTLE (70954-912-10) Hydroxyzine Hydrochloride ANI Pharmaceuticals, Inc. 2026-01-15
71656-0090-16 473 mL in 1 BOTTLE (71656-090-16) Hydroxyzine Hydrochloride Saptalis Pharmaceuticals, LLC. 2026-06-17
81033-0031-44 40 CUP, UNIT-DOSE in 1 CARTON (81033-031-44) / 5 mL in 1 CU... Hydroxyzine Hydrochloride Kesin Pharma 2026-02-27
81033-0031-45 40 CUP, UNIT-DOSE in 1 CARTON (81033-031-45) / 12.5 mL in 1... Hydroxyzine Hydrochloride Kesin Pharma 2026-02-27
83745-0232-16 473 mL in 1 BOTTLE (83745-232-16) HYDROXYZINE HYDROCHLORIDE APOZEAL PHARMACEUTICALS INC 2024-07-16
Observed labelers: Chartwell RX, LLC (3) · Kesin Pharma (2) · ANI Pharmaceuticals, Inc. (1) · APOZEAL PHARMACEUTICALS INC (1) · ATLANTIC BIOLOGICALS CORP. (1) · Bionpharma Inc. (1) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.